Press Releases

72% of GenXers and Boomers Reported Hearing Loss Has Negative Impacts on Mental, Physical, and Financial Health Although New Survey Reveals Widespread Inaction Among Aging Americans

MINNEAPOLIS--(BUSINESS WIRE)-- A new survey conducted by Miracle-Ear , an Amplifon company, found that the Gen X and Baby Boomer populations, those 44 - 78 years old, have already been impacted by hearing loss to some degree. With more than seven decades of caring for Americans’... (continue reading...)

CAMBRIDGE, Mass., June 13, 2024 (GLOBE NEWSWIRE) -- Toll Brothers Apartment Living, the rental subsidiary of Toll Brothers, Inc. (NYSE: TOL), the nation's leading builder of luxury homes, along with joint venture partner PGIM, announced the grand opening of The Laurent, a new seven-story, 525-unit luxury mid-rise multifamily community in Cambridge, Massachusetts. Construction of The Laurent was financed through a $142 million construction loan facility from Wells... (continue reading...)

PBMs are Leeches: First video spot explains pharmacy benefit managers' role in higher drug prices

ALEXANDRIA, Va., June 13, 2024 /PRNewswire/ -- The National Community Pharmacists Association (NCPA) today launched an all-out push for payment reform that educates patients on how pharmacy benefit managers are increasing prescription drug prices. The national campaign, featuring television, digital and print ads, aims to push Congress to enact PBM payment reform that has... (continue reading...)

$64.8 million will fund 322 housing initiatives in all 67 counties 

HARRISBURG, Pa., June 13, 2024 /PRNewswire/ -- The Pennsylvania Housing Finance Agency today announced the recipients of a new round of funding for housing programs made available through the Pennsylvania Housing Affordability and Rehabilitation Enhancement (PHARE) fund. PHFA has identified 322 housing and community development initiatives in all 67 counties that will share a portion of the total... (continue reading...)

Former CSO of Trilo Therapeutics and Research Fellow at AbbVie joins to lead BioLoomics’ pipeline and combine lysosome targeting antibodies with ADCs

BOULDER, Colo.--(BUSINESS WIRE)-- BioLoomics, a biotechnology company that targets peptide-antibody chimeras to specific compartments inside of diseased cells, announced today that Kurt Gish, Ph.D., has joined as the Chief Scientific Officer. Dr Gish will focus on building the company’s pipeline of lysosomal... (continue reading...)